PATENT CLAIM ANALYSIS

Application Number: 15894615
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "263100"]

Abstract:
A composition for inhibiting α-glucosidase has lower side effects to a user, other than the inhibition of α-glucosidase. The composition comprises adenine, (3-hydroxy-dl-proline, nicotinic acid, (3,6-dioxo-piperazin-2-yl)-acetic acid amide, 2-ethylhexyl heptanoate, and a pharmaceutically compatible salt.

Claim (Index 3):
The composition of  claim 1 , wherein the composition inhibits \u03b1-glucosidase in intestinal track, and reduce digestive rate of saccharides.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.30556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15636641', '13038513', '13061038', '14547537', '13124150']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6957713874127451
- 35 USC 102 Novelty (BERT): 0.4850118430233166
- Combined Prediction Score: 0.6746954329738023
- Mean Citation Score: 113.09730199999998
- Max Citation Score: 117.36425
- Similarity Product: 77.53449693587422

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test